Czech National Bank boosted its stake in CVS Health Co. (NYSE:CVS – Free Report) by 7.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 256,430 shares of the pharmacy operator’s stock after buying an additional 17,206 shares during the period. Czech National Bank’s holdings in CVS Health were worth $16,124,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the stock. Pzena Investment Management LLC grew its holdings in CVS Health by 132.9% during the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock worth $764,023,000 after acquiring an additional 7,382,931 shares in the last quarter. Capital International Investors grew its stake in shares of CVS Health by 12.5% during the first quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock worth $3,024,334,000 after purchasing an additional 4,226,225 shares in the last quarter. Capital World Investors increased its holdings in CVS Health by 8.0% in the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after buying an additional 3,232,172 shares during the last quarter. State of Michigan Retirement System increased its holdings in shares of CVS Health by 402.5% in the 2nd quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock valued at $118,455,000 after acquiring an additional 1,606,500 shares during the last quarter. Finally, Junto Capital Management LP purchased a new stake in CVS Health during the fourth quarter worth approximately $111,209,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.
CVS Health Price Performance
Shares of CVS traded up $1.67 during mid-day trading on Friday, reaching $64.59. 16,313,877 shares of the company’s stock were exchanged, compared to its average volume of 11,032,696. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The company has a 50-day simple moving average of $58.60 and a two-hundred day simple moving average of $61.58. The company has a market cap of $81.08 billion, a price-to-earnings ratio of 11.36, a PEG ratio of 0.81 and a beta of 0.54.
CVS Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.12%. The ex-dividend date is Monday, October 21st. CVS Health’s payout ratio is 46.75%.
Analyst Ratings Changes
CVS has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft dropped their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $59.00 to $85.00 in a research report on Friday. Wells Fargo & Company raised their price objective on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Finally, Barclays reduced their target price on CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a report on Thursday, August 8th. Ten equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $73.40.
Get Our Latest Stock Analysis on CVS
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
- Five stocks we like better than CVS Health
- What to Know About Investing in Penny Stocks
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- What Are Dividend Contenders? Investing in Dividend Contenders
- MarketBeat Week in Review – 9/30 – 10/4
- Learn Technical Analysis Skills to Master the Stock Market
- Top Streaming Companies: Who’s Winning the Battle?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.